The Latest Breaking News on Pharma

More than a year after the maker of OxyContin reached a tentative settlement over the toll of opioids, the money isn't flowing yet

Given the pharmaceutical industry’s robust growth prospects, drug-maker Neurocrine Biosciences’ (NBIX) stock is worth watching ahead of its first-quarter earnings next week. Read on….

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

Leading biotech company Regeneron Pharmaceuticals (REGN) has exhibited robust financial growth in recent years. With the biotech industry’s promising prospects, this stock might be a solid portfolio addition now. Read on….

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand

Along with the stethoscope and camembert cheese, mifepristone may be one of France’s greatest inventions. It’s one of two drugs taken for medical abortions, along with misoprostol, and has been making headlines in the US, where a Texas judge issued a ruling to ban it nationwide. FRANCE 24 takes a…

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

Hull-founded firm enjoying double digit expansion in largest established market as it awaits consent for East Yorkshire build

The extension of dispensing timelines on hundreds of medications will lead to pharmacies closing and impact healthcare access, according to pharmacists in regional NSW.

U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease